快速对比At a Glance

为不同医院选择合适的配置Right configuration for every hospital

向术 AIR
向术 AIR · 入门型Xiangshu AIR · Entry

便携箱式 —— 把空间智能装进出诊包Case-format — Spatial AI in a carry-case

为基层医院、教学场景与术前规划而生。MR 头显 + 工控机 + 显示屏装在一个工业级便携箱中,10 分钟即可启用。无需手术室基础设施改造,特别适合医学院校教学与县级医院推广。Built for regional hospitals, teaching, and preoperative planning. Headset + workstation + display ship in an industrial case — operational in 10 minutes. No OR infrastructure changes required.

  • MR 头显(HoloLens 2 / Magic Leap 2 / 国产可选)MR Headset (HoloLens 2 / Magic Leap 2 / domestic options)
  • 便携工业级工控机 + 触屏显示器Industrial-grade portable workstation + touch display
  • 完整 LIBR 算法栈 + 软件订阅Full LIBR algorithm stack + software subscription
  • 面向教学的多用户同步查看模式Multi-user synchronized view for teaching scenarios
ASP
¥80-150万
¥0.8-1.5M
部署时间Deployment
10 min
向术 CORE
向术 CORE · 旗舰Xiangshu CORE · Flagship

移动支架 —— 三甲医院的标准配置Mobile cart — the standard for Tier-3 ORs

向术 CORE 是我们的旗舰产品,也是首批进入 NMPA 三类注册的肝脏手术导航整机。标准化的移动支架配置可直接进入手术室,所有外设、传感器、显示集成在一个移动平台上。CORE is our flagship — the first liver-surgery navigation system entering NMPA Class III registration. A standardized mobile cart brings all displays, sensors, and instruments into the OR on a single platform.

  • 医疗级移动支架 + 双 4K 显示屏Medical mobile cart + dual 4K displays
  • 完整 7 大核心能力,含 LIBR 形变矫正All 7 core capabilities incl. LIBR correction
  • Virtual IFSH 实时切缘评估(乳腺)Virtual IFSH real-time margin assessment (breast)
  • 微波消融实时导航与消融区预测(肝胆)Microwave ablation live guidance + zone prediction (hepatobiliary)
  • 推荐用于复旦中山、协和、301、华西等顶级中心Recommended for top-tier centers (Zhongshan, PUMCH, 301, West China, etc.)
ASP
¥150-300万
¥1.5-3M
订阅Subscription
¥30-60万/年¥0.3-0.6M/yr
单院回收期ROI
~2.5-3 yr
向术 PRO
向术 PRO · 专业型Xiangshu PRO · Pro

机械臂集成 —— 主动感知的智能副驾Cobot-integrated — the active-perception co-pilot

向术 PRO 在 CORE 基础上集成 KUKA LBR Med 或 KINOVA Gen3 协作机械臂,搭载 NDI Polaris Lyra 光学追踪与 ZED 2i 立体相机的多传感器末端。机械臂从被动设备变成主动观察者 —— 自动重定位以保持最佳观察角度、自动避让医生手部。PRO adds a KUKA LBR Med or KINOVA Gen3 cobot with multi-sensor head (NDI Polaris Lyra + ZED 2i). The cobot transforms from a passive device into an active observer — auto-repositioning for optimal view and avoiding surgeon hands automatically.

  • 医疗合规协作机械臂(KUKA LBR Med / KINOVA Gen3 Med)Medical-grade cobot (KUKA LBR Med / KINOVA Gen3 Med)
  • NDI Polaris Lyra 亚毫米光学追踪NDI Polaris Lyra sub-millimeter optical tracking
  • 远程 / 示教 / 自主三种工作模式Remote / Teach / Autonomous modes
  • 支撑前沿临床研究与新术式开发Enables advanced clinical research and new procedure development
ASP
¥300-500万
¥3-5M
追踪精度Accuracy
< 1mm
光学追踪配件
光学追踪配件Optical Tracking Accessories

适配多种手术器械的被动标志物Passive markers across surgical instruments

基于反射球技术的光学追踪配件可适配现有手术器械,无需更换医院已有工具集。配件与向术 AIR / CORE / PRO 系列全兼容。耗材类项目,构成持续性销售收入。Retro-reflective marker accessories adapt to existing surgical instruments — no need to replace hospital tool sets. Compatible with Xiangshu AIR / CORE / PRO. A consumable line for recurring revenue.

  • 兼容 NDI 与头显内向外光学追踪Compatible with NDI and headset inside-out optical tracking
  • 微波探针 / 切除器 / 超声探头 / 自由器械适配方案Adapters for microwave probes, resection tools, ultrasound probes, custom instruments
  • EO 灭菌 / 高温高压 / 消毒液 多种处理方式EO sterilization / autoclave / disinfectant cleaning options
四阶段路线图Four-Phase Roadmap

从智能导航到 Spatial AI 平台From smart navigation to Spatial AI platform

26-27
阶段一 · 智能导航Phase 1 · Smart Navigation
肝脏 CORE 完成产品定型与三类 NMPA 注册申报递交,启动多中心 IRB 临床试验(华东优先),完成乳腺导航系统集成。8-10 家三甲临床合作。CORE liver system finalized + NMPA Class III filing submitted. Multi-center IRB trials (East China first). Breast nav system integrated. 8-10 Tier-3 hospital partnerships.
27-29
阶段二 · 智能感知Phase 2 · Smart Sensing
完成肝脏 NMPA 三类取证、商业化首单;PRO 工程化样机;乳腺注册申报;胰腺/前列腺产品适配;FDA(510(k))与 CE MDR 预申报。NMPA approval secured for liver, first commercial sales. PRO production prototype + cobot integration. Breast registration. Pancreas/prostate adaptation. FDA 510(k) + CE MDR pre-submissions.
29-31
阶段三 · 智能协作 / 国际化Phase 3 · Smart Collaboration / International
与国产手术机器人厂商 OS 级协同;Virtual IFSH 多中心注册;海外业务从亚太、欧洲启动。目标 2031 年累计装机 200+ 台、营收 3-6 亿元。OS-level integration with Chinese robotic surgery vendors. Virtual IFSH multi-center registration. APAC + EU rollout. Target 2031: 200+ installations, ¥300-600M revenue.
31+
阶段四 · Spatial AI 平台Phase 4 · Spatial AI Platform
开放 SDK 与 API,形成外科 AI 模型市场;数据增值服务、远程指导、医生培训成为新收入支柱。目标占据全球软组织手术导航市场 10-15% 份额。Open SDK & API for third-party algorithms. Data services, remote guidance, surgeon training as new revenue pillars. Target 10-15% global soft-tissue navigation market share.

想为您的医院安排现场演示?Want a live demo at your hospital?

我们为合作伙伴提供 HoloLens 2 / Magic Leap 2 现场演示与术中模拟。We offer HoloLens 2 / Magic Leap 2 live demonstrations and intraoperative simulations.